Munich-based Ortivity just closed a €200 million funding round led by Apheon, with backing from Unigestion Private Equity. Founded by Dr. med. Reinhard Wichels, alongside private equity partner Apheon, Ortivity is merging clinical expertise with a digital-first operational strategy to tackle the deeply fragmented orthopaedic market.
With fresh leadership that brings deep expertise in healthcare transformation, the funding will accelerate expansion beyond Germany and enhance tech infrastructure. While data analytics and AI are part of the company’s toolkit, the core tech advantage lies in digitally optimising outpatient orthopaedics.
The company’s platform is a tech-enabled ecosystem designed to integrate scheduling, diagnostics, treatment coordination, and post-op care into a seamless experience for patients and providers. This approach addresses inefficiencies and uneven quality in traditional orthopaedic practices, enabling Ortivity to rapidly scale to over 100 sites across Germany’s key markets.
What sets Ortivity apart is its physician-partner ownership model, which anchors clinical excellence, while a robust tech backbone drives standardisation and operational efficiency. In comparison to competitors like KINIOS or standalone MVZ centres, Ortivity stands out by building a scalable, data-informed platform engineered for consistent patient outcomes at scale.
